To examine the consequences of the immune modulation seen in chronic filarial infection on responses to intracellular pathogens (and their antigens) that are often co-endemic with filarial infections, namely Plasmodium and Mycobacterium tuberculosis.
INTRODUCTION
Filarial worms are nematodes that dwell in the subcutaneous tissues and the lymphatics. Eight filaria species infect humans. Of these eight, fourWuchereria bancrofti, Brugia malayi, Onchocerca volvulus, and Loa loa -are considered to be significantly pathogenic in humans. Filarial parasites, infecting an estimated 200 million persons worldwide, are transmitted by specific species of mosquitoes or other arthropods and have a complex life-cycle including infective larval stages harbored by insects and adult worms that reside in either lymphatics or subcutaneous tissues of humans. The offspring of adults are microfilariae that either circulate in the blood or migrate through the skin and are the major antigenic reservoir in the host. The Rickettsia-like endosymbiont Wolbachia has been found intracellularly in all stages of Brugia, Wuchereria, Mansonella, and Onchocerca and has been suggested to mediate some of the pathology associated with these infections.
The overlapping geographic distributions of filarial infections, malaria, and tuberculosis (particularly in Africa and on the Indian subcontinent) demonstrate very clearly that, on a population level, the potential for interaction among these pathogens can occur. Because each of these organisms has quite different anatomic predilections, the interplay among them is most likely indirect and related, in large part, to the differing immunological responses each pathogen induces as well as to the compartments (anatomic and cellular) each pathogen is associated with. Moreover, the temporal differences in the acquisition of the infections must also play a significant role. For example, in most coendemic regions, acquisition of filarial infections precedes infection with Mycobacterium tuberculosis (Mtb), whereas malarial infection occurs early in life and likely precedes the acquisition of both filaria and M. tuberculosis infections.
The hallmark of the immune response in individuals with patent (or active) filaria infections of all species is a profound inability of CD4 þ cells to proliferate or produce cytokines associated with a Type-1 (IL-2 and IFN-g) and Type 2 (IL-5) response following parasite antigen stimulation in vitro. This parasite-specific anergy is mediated primarily by IL-10 and, to a lesser extent, by TGF-b. Although the immune downmodulation associated with filarial infections is parasite antigen-specific relatively early in infection, over time some bystander effects on nonparasitic antigen-specific responses, routine vaccinations, allergic processes, and autoimmune diseases have been noted (Fig. 1) .
Despite the differences in basic biology, compartmental niches, genetic components, and host-cell reservoirs between Plasmodium species and Mtb, the approach taken in this review will examine the interface between the tissue invasive filariae and either tuberculosis or malaria. Because of
KEY POINTS
Filarial infections profoundly modulate mycobacteria antigen-specific and malaria antigen-specific immune responses in vitro through filaria-induced IL-10 or TGF-b and through the increased expression of the negative costimulatory molecules -CTLA-4 and PD-1.
The effect of filarial infections on the disease (tuberculosis and malaria) progression and/or outcome is still unknown.
There is a lack of suitable animal models or large human studies of mycobacteria/filaria or malaria/ filaria co-infections to definitively ascertain the interplay between filaria and malaria or tuberculosis. 
FILARIA INFECTIONS AND MYCOBACTERIA INFECTIONS
In the nontuberculous M. leprae infection, the incidence of lepromatous leprosy was twice as high in areas where onchocerciasis was co-endemic than in those areas without onchocerciasis [1] . Onchocerciasis has also been shown to modulate delayed type hypersensitivity to tuberculin skin testing in adults in Mali [2] and in Chad [3] and to mycobacteria antigens (in vitro) in children [4] . In contrast, coincident lymphatic filarial infection had no significant influence on tuberculin skin test positivity in a population endemic for both W. bancrofti (Wb) and hookworm infections and tuberculosis in South India [5] . The question of whether bacillus CalmetteGuérin (BCG) vaccination at birth may bias the immune response toward a lasting Type-1 response and consequently decrease susceptibility to filaria infection is still unanswered, although a number of longitudinal cohort studies are hoping to address this specifically. The immunogenicity of BCG vaccination has been shown to be impaired in nonfilarial nematode-infected individuals and this is associated with enhanced TGF-b production but not enhanced Th2 responses [6, 7] . On balance, in-vitro responses to nonparasitic antigens including the mycobacteria antigens [purified protein derivative (PPD), culture filtrate protein (CFP), and crude Mtb extract] appear to remain largely intact (as measured by lymphocyte proliferation and/or IFN-g production) in those with filarial infection (Table 1) , and Type-1 responses to mycobacteria antigens are relatively normal [28] , although several studies have documented a poor response to PPD in vitro in onchocerciasis [16, 29] .
FILARIAL MODULATION OF IMMUNE RESPONSES IN MYCOBACTERIAL INFECTIONS
The control of tuberculosis requires clearly delineated Th1 responses (IL-12, IFN-g, and TNF-a) and, to a lesser extent, Th17 responses (IL-17A and IL-23), with both T-cell subsets playing important roles in the induction and maintenance of protective impairment of resistance to secondary infection with Mtb. Moreover, IL-4R receptor-mediated alternative activation of macrophages was shown to be primarily responsible for this impaired resistance [34 && ]. The effect of preexposure to filaria parasites on the responses of antigen-presenting cells (APCs) to subsequent Mtb infection has been studied using dendritic cells and macrophages in vitro. It was shown that dendritic cells and macrophages are comparatively less mature in phenotype and secrete significantly fewer proinflammatory cytokines in response to Mtb infection in the context of coincident exposure to filaria parasites. In addition, the surface expression of one of the receptors used by Mtb to enter APCs, DC-SIGN (CD209), is also downregulated by preexposure to filaria parasites, suggesting that these cells are rendered less susceptible to Mtb infection. ]. Filarial infections also have the additional effect of modulating the expression and function of Toll-like receptors (TLRs), specifically TLR2 and TLR9, and this attenuation can be corrected by antifilaria chemotherapy [35] .
This situation suggests that filarial infections can modulate various levels of Mtb-specific responses though whether this mediates predisposition to the development of active tuberculosis awaits clarification. From a purely mechanistic point of view, filarial infections -because of their chronicity and the prototypical immune responses (e.g. Th2, IL-10, TGF-b, Tregs) they engender -clearly should modulate those responses (IL-12, IFN-g, and IL-17) associated with susceptibility to active tuberculosis. Definitive proof, however, of this phenomenon is lacking not only in animal models of filaria/mycobacteria co-infections, but also in population-based human studies.
FILARIA AND PLASMODIUM CO-INFECTION
Human filaria and Plasmodium infections are the most prevalent vector-borne parasitic diseases worldwide and they thrive in the same geographical regions. Of the pathogens that can concomitantly occupy the same circulatory niche in the human host, malaria holds primacy as the disease-causing bloodstream infectious agent. In some areas of the world with anopheline transmission of lymphatic filariasis (e.g. West Africa, Papua New Guinea), the two infections are transmitted by the same mosquito vector [36] [37] [38] .
The presence of the two parasites in the same host (co-infection) has been described in different parts of the world with varying prevalence. For example, the prevalence of people co-infected with malaria and Wb ranged from 0.3 to 0.4% in India [39, 40] , was 3.3% in parts of South America [38] , 4.3% in Kenya [41] , and 11.1% in Tanzania [42] . Mansonella perstans (Mp) and Plasmodium co-infections were reported in 18% of pregnant women in a filarial-endemic region of Uganda [43] . Filaria co-infections with Plasmodium have been studied in both animal models and humans [26,44- 
FILARIAL MODULATION OF IMMUNE RESPONSE IN MALARIA
Individually, filarial and malaria infections induce contrasting immune responses (Fig. 2) with human filarial infection being associated with expansion of Foxp3-expressing natural (nTreg) and IL-10-producing and TGF-b-producing adaptive (Tr1 and Th3, respectively) regulatory T cells [50] [51] [52] 53 & ,54] and P. falciparum infection being characterized by the production of proinflammatory cytokines including -among many others -IL-1, IL-6, IL-12, CXCL-9, CXCL-10, TNF-a, IFN-g, and associated Th1 cytokines [55,56,57 & ,58,59] . Protection against malaria is postulated to be mediated by both cell-mediated and humoral (cytophilic antibodies) immune responses [55] . Of all the studies of helminth and Plasmodium co-infections in animal models, only very few have used the animal models of filarial infection (Table 2) to study the modulation of malaria-specific immune responses. In these few, no unifying theme has emerged in that one study found that co-infection exacerbated malaria severity [45] , whereas several others found that filarial infection protected mice against severe disease [44,46,48 & ]. This ambiguity might be partially attributable to differences in the species of malaria parasites or filarial organisms [60, 61] and/or in differences in mouse strains used [62] .
Using a co-infection model with P. chabaudi chabaudi AS and L. sigmodontis in BALB/c mice, coinfected mice had more severe disease compared with malaria only infected mice. Malaria was more severe in amicrofilaremic mice compared with microfilaremic mice, and this situation was associated with increased IFN-g production [45] . In this mouse model, however, Plasmodium infection is not lethal but induces proinflammatory cytokines that help control parasitemia [63] with the levels of proinflammatory cytokines being the determinant of successful control or exacerbation [64] . In a model using CBA/J mice, irradiated infective larva (L3) of Brugia pahangi and P. berghei-infected erythrocytes, co-infected mice induced high levels of Th2 cytokines and protected mice from cerebral malaria [46] . This filaria-induced resistance to cerebral malaria was recently confirmed in a P. berghei and L. sigmodontis co-infection model in C57BL/6 mice that was IL-10 dependent and related to reduced T-cell infiltration of the brain [48 & ]. In a the more permissive BALB/c mouse model, it was found that 30% of mice infected with L. sigmodontis failed to develop parasitemia after P. berghei sporozoite infection, with microfilaremic co-infected mice exhibiting greater resistance to malaria parasitemia than in amicrofilaremic co-infected mice [44] . These mouse studies, in aggregate, suggest that modulation of malaria infection by filaria parasites depends on the patency of the filarial infection and the regulatory environment induced when infection reaches patency.
Although several studies have reported concomitant malaria and filarial infections in areas around the world, only a few studies have investigated the impact of filarial infection on the immune response to malaria (Table 3 ). In a human L. loa and P. malariae co-infection study, frequencies of Th2 cells were significantly higher in co-infected compared with those with P. malariae only infected patients [49] .
More recently, a series of studies in Mali coendemic for the filaria parasites Wb and Mp and P. falciparum has demonstrated that patent filarial infection was associated with lowered production of malaria-specific IL-12p70, CXCL-10, and IFN-g that was IL-10-dependent [26] . Using multiparameter flow cytometry, filarial infection was shown to be associated with low frequencies of malaria-specific Th1, 'TNF-a', and Th17 CD4 þ T cells but higher frequencies of nTreg and aTreg/Tr1 and a complete absence of multifunctional Th1 cells [47 & ]. As Th1 differentiation is under the control of IL-12 production by APCs [66] [67] [68] , the role of APCs in this Th1 downmodulation was investigated and it was found that filaria parasite-mediated suppression of the interferon regulatory factors (IRFs), particularly IRF-1 specifically in myeloid dendritic cells regulates IL-12 production and may underlie the Th1 downmodulation seen in Plasmodium/filaria co-infection [65] .
CONCLUSION
Although phylogenetically distinct, mycobacteria and Plasmodium spp. often share the same geographical niche with filarial infections. As such, they cannot always be studied in isolation, but rather the important interactions among them must be considered. The complex interplay between filaria parasites that are associated with immunomodulation and those microbial pathogens that require a proinflammatory or unmodulated response for their control is easily demonstrable ex vivo, but whether this interplay affects disease outcome in either Mtb infection or malaria remains an open question. 
